These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 33673277)
21. Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first-episode mania and association with clinical outcome. Kozicky JM; McGirr A; Bond DJ; Gonzalez M; Silveira LE; Keramatian K; Torres IJ; Lam RW; Yatham LN Bipolar Disord; 2016 Sep; 18(6):511-519. PubMed ID: 27759214 [TBL] [Abstract][Full Text] [Related]
22. Cytokines in bipolar disorder: paving the way for neuroprogression. Barbosa IG; Bauer ME; Machado-Vieira R; Teixeira AL Neural Plast; 2014; 2014():360481. PubMed ID: 25313338 [TBL] [Abstract][Full Text] [Related]
23. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator. Machado-Vieira R J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970 [TBL] [Abstract][Full Text] [Related]
24. Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression. Pfaffenseller B; Wollenhaupt-Aguiar B; Fries GR; Colpo GD; Burque RK; Bristot G; Ferrari P; Ceresér KM; Rosa AR; Klamt F; Kapczinski F Int J Neuropsychopharmacol; 2014 Sep; 17(9):1453-63. PubMed ID: 24800824 [TBL] [Abstract][Full Text] [Related]
26. Refractory bipolar disorder and neuroprogression. da Costa SC; Passos IC; Lowri C; Soares JC; Kapczinski F Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():103-10. PubMed ID: 26368941 [TBL] [Abstract][Full Text] [Related]
27. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Bakunina N; Pariante CM; Zunszain PA Immunology; 2015 Mar; 144(3):365-373. PubMed ID: 25580634 [TBL] [Abstract][Full Text] [Related]
28. The Adverse Effects of Smoking on Health Outcomes in Bipolar Disorder: A Review and Synthesis of Biological Mechanisms. Slyepchenko A; Brunoni AR; McIntyre RS; Quevedo J; Carvalho AF Curr Mol Med; 2016; 16(2):187-205. PubMed ID: 26812916 [TBL] [Abstract][Full Text] [Related]
29. The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder. Bauer IE; Soares JC; Selek S; Meyer TD Mod Trends Pharmacopsychiatry; 2017; 31():10-26. PubMed ID: 28738324 [TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Kim Y; Santos R; Gage FH; Marchetto MC Front Cell Neurosci; 2017; 11():30. PubMed ID: 28261061 [TBL] [Abstract][Full Text] [Related]
31. Cognitive deficits in bipolar disorders: Implications for emotion. Lima IMM; Peckham AD; Johnson SL Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773 [TBL] [Abstract][Full Text] [Related]
32. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications. Rosenblat JD; Brietzke E; Mansur RB; Maruschak NA; Lee Y; McIntyre RS J Affect Disord; 2015 Dec; 188():149-59. PubMed ID: 26363613 [TBL] [Abstract][Full Text] [Related]
33. [Bipolar disorder: staging and neuroprogression]. Rodrigues AA; Rosa AR; Kunz M; Bruna A; Kapczinski F Psychiatr Pol; 2014; 48(2):231-43. PubMed ID: 25016762 [TBL] [Abstract][Full Text] [Related]
34. Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. Machado-Vieira R; Soeiro-De-Souza MG; Richards EM; Teixeira AL; Zarate CA World J Biol Psychiatry; 2014 Feb; 15(2):84-95. PubMed ID: 23998912 [TBL] [Abstract][Full Text] [Related]
35. Weight gain as a predictor of frontal and temporal lobe volume loss in bipolar disorder: A prospective MRI study. Bond DJ; Su W; Honer WG; Dhanoa T; Batres-Y-Carr T; Lee SS; Torres IJ; Lam RW; Yatham LN Bipolar Disord; 2019 Feb; 21(1):50-60. PubMed ID: 30422375 [TBL] [Abstract][Full Text] [Related]
36. Mediators of allostasis and systemic toxicity in bipolar disorder. Grande I; Magalhães PV; Kunz M; Vieta E; Kapczinski F Physiol Behav; 2012 Apr; 106(1):46-50. PubMed ID: 22079584 [TBL] [Abstract][Full Text] [Related]
37. Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder. van den Ameele S; Fuchs D; Coppens V; de Boer P; Timmers M; Sabbe B; Morrens M Front Psychiatry; 2018; 9():250. PubMed ID: 29962973 [No Abstract] [Full Text] [Related]
38. Mitochondria, endoplasmic reticulum and innate immune dysfunction in mood disorders: Do Mitochondria-Associated Membranes (MAMs) play a role? Resende R; Fernandes T; Pereira AC; De Pascale J; Marques AP; Oliveira P; Morais S; Santos V; Madeira N; Pereira CF; Moreira PI Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165752. PubMed ID: 32119897 [TBL] [Abstract][Full Text] [Related]
39. A longitudinal proton magnetic resonance spectroscopy study investigating oxidative stress as a result of alcohol and tobacco use in youth with bipolar disorder. Chitty KM; Lagopoulos J; Hickie IB; Hermens DF J Affect Disord; 2015 Apr; 175():481-7. PubMed ID: 25679204 [TBL] [Abstract][Full Text] [Related]